# US 2020/0390910 A1 · Process for producing a contrast agent

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0390910 A1
- Document ID: US20200390910A1
- Status: Published application
- Kind: A1
- Application number: 16/971,734
- Filed: 2019-02-20
- Published: 2020-12-17
- Earliest claimed: 2018-02-23
- Assignees: Sanochemia Pharmazeutika AG
- Applicants: Sanochemia Pharmazeutika GmbH
- Inventors: Stefan WELZIG; Beate KÄLZ; József GUNGL; Klaus GERDES; Roswitha BRAUNRATH; Christina ABRAHAMSBERG
- Web page: https://patentgrep.com/patent/US20200390910A1

## CPC

- A61K 49/108: {the metal complex being Gd-DOTA}
- C07D 257/02: not condensed with other rings
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Disclosed is a process for producing a contrast agent-containing pharmaceutical preparation, which contains as the contrast agent a complex of a lanthanide, in particular gadolinium, and a macrocyclic chelate, in particular DOTA.

## Claims

### Claim 1

Method for producing a liquid, in particular aqueous, preparation containing, as contrast agent, in particular as contrast agent for magnetic resonance, a complex of a lanthanide and a macrocyclic chelate, the preparation containing free macrocyclic chelate, the method comprising:
a) dissolving macrocyclic chelate in water,
b) adding a lanthanide,
c) adding a base,
d) carrying out the complexing of the lanthanide with the macrocyclic chelate, in the presence of the base, at a pH above 5.5, in particular at a pH between 6.5 and 8.0,
e) adjusting the pH of the solution obtained after step d) to a value below 5.0,
f) adjusting the pH to a value above 6.5, and
g) diluting the solution obtained after step g) to the specified final volume.

### Claim 2 (depends on 1)

The method according to claim 1, wherein gadolinium is used as lanthanide.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the lanthanide is used as oxide, in particular gadolinium as gadolinium oxide.

### Claim 4 (depends on 1)

The method according to claim 1, wherein DOTA is used as the macrocyclic chelate.

### Claim 5 (depends on 1)

The method according to claim 1, wherein in step c) an organic base is added.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the base is added in step c) in a deficit with respect to the lanthanide used.

### Claim 7 (depends on 1)

The method according to claim 1, wherein DOTA is used to adjust the pH in step e).

### Claim 8 (depends on 1)

The method according to claim 1, wherein the pH in step f) is adjusted to a value between 6.5 and 8.0, in particular to a value between 6.8 and 7.5.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the adjustment of the pH in step f) is carried out with a base, in particular with meglumine.

### Claim 10 (depends on 1)

The method according to claim 1, wherein lanthanide and the macrocyclic chelate are used in molar amounts different from one another or in equal molar amounts.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the macrocyclic chelate is used in a deficit with respect to the lanthanide used.

### Claim 12 (depends on 1)

The method according to claim 1, wherein chelate, in particular DOTA, in particular up to a content of 500 to 799 ppm, is added after step e).

### Claim 13 (depends on 1)

The method according to claim 1, wherein the base, in particular meglumine, is present in a stoichiometric deficit with respect to the lanthanide used and in a stoichiometric surplus with respect to the macrocyclic chelate used.

### Claim 14 (depends on 1)

The method according to claim 1, wherein the lanthanide is in a stoichiometric surplus with respect to the macrocyclic chelate when step d) is carried out.

### Claim 15 (depends on 1)

The method of claim 1, wherein step f) is performed to adjust the pH to a value above 7.0.

### Claim 16 (depends on 1)

The method of claim 1, wherein step f) is performed to adjust the pH to a value between 7.0 and 7.5.

### Claim 17 (depends on 2)

The method according to claim 2, wherein the lanthanide is used as oxide, in particular gadolinium as gadolinium oxide.

### Claim 18 (depends on 2)

The method according to claim 2, wherein DOTA is used as the macrocyclic chelate.

### Claim 19 (depends on 3)

The method according to claim 3, wherein DOTA is used as the macrocyclic chelate.

### Claim 20 (depends on 5)

The method of claim 5, wherein the organic base is meglumine.
